138 related articles for article (PubMed ID: 37378922)
1. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia.
Aref S; El Tantawy A; Gouda E; Ayed M
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
[TBL] [Abstract][Full Text] [Related]
2. CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia.
D'Arena G; Vitale C; Coscia M; Lamorte D; Pietrantuono G; Perutelli F; D'Auria F; Statuto T; Valvano L; Tomasso A; Griggio V; Jones R; Mansueto G; Villani O; D'Agostino S; Viglioglia V; De Feo V; Calapai F; Mannucci C; Sgambato A; Efremov DG; Laurenti L
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439393
[TBL] [Abstract][Full Text] [Related]
3. Circulating CXCL13 could be serving as a biomarker for chronic lymphocytic leukemia severity.
Aref S; Atia D; Ramez A; Zeid TA; Gouda E
Cancer Biomark; 2022; 34(1):105-111. PubMed ID: 34719478
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice.
Wong KK; Brenneman F; Chesney A; Spaner DE; Gorczynski RM
Cancer Res; 2012 Oct; 72(19):4931-43. PubMed ID: 22875025
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.
Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
[TBL] [Abstract][Full Text] [Related]
6. Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression.
Twito T; Chen Z; Khatri I; Wong K; Spaner D; Gorczynski R
Leuk Res; 2013 Jul; 37(7):816-21. PubMed ID: 23643150
[TBL] [Abstract][Full Text] [Related]
7. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
[TBL] [Abstract][Full Text] [Related]
8. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD200 Ectodomain Shedding.
Wong KK; Zhu F; Khatri I; Huo Q; Spaner DE; Gorczynski RM
PLoS One; 2016; 11(4):e0152073. PubMed ID: 27111430
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
12. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
[TBL] [Abstract][Full Text] [Related]
13. Serum copper is a simple but valuable prognostic marker in B-cell chronic lymphocytic leukemia.
Labib HA; Hassanein M; Etewa RL
Int J Hematol; 2014 Dec; 100(6):575-81. PubMed ID: 25293553
[TBL] [Abstract][Full Text] [Related]
14. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
15. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
[TBL] [Abstract][Full Text] [Related]
17. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
Abo Elwafa R; Abd Elrahman A; Ghallab O
Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
[TBL] [Abstract][Full Text] [Related]
18. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.
Matuszak M; Lewandowski K; Czyż A; Kiernicka-Parulska J; Przybyłowicz-Chalecka A; Jarmuż-Szymczak M; Lewandowska M; Komarnicki M
Leuk Res; 2016 Aug; 47():166-71. PubMed ID: 27376546
[TBL] [Abstract][Full Text] [Related]
20. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
